Involvement of the Spinal Cord in Primary Mitochondrial Disorders: A Neuroimaging Mimicker of Inflammation and Ischemia in Children

References

1. 1.↵
   1. Rahman J,
   2. Rahman S

   . Mitochondrial medicine in the omics era. Lancet 2018;391:2560–74 doi:10.1016/S0140-6736(18)30727-X pmid:29903433

   CrossRefPubMed
2. 2.↵
   1. Finsterer J,
   2. Zarrouk-Mahjoub S

   . Involvement of the spinal cord in mitochondrial disorders. J Neurosci Rural Pract 2018;9:245–51 doi:10.4103/jnrp.jnrp_446_17 pmid:29725177

   CrossRefPubMed
3. 3.↵
   1. van der Knaap MS,
   2. van der Voorn P,
   3. Barkhof F, et al

   . A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann Neurol 2003;53:252–58 doi:10.1002/ana.10456 pmid:12557294

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Lin T-K,
   2. Chang Y-Y,
   3. Lin H-Y, et al

   . Mitochondrial dysfunctions in leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL). PLoS One 2019;14:e0224173 doi:10.1371/journal.pone.0224173 pmid:31671122

   CrossRefPubMed
5. 5.↵
   1. Cavanagh JB,
   2. Harding BN

   . Pathogenic factors underlying the lesions in Leigh’s disease. Brain 1994;117:1357–76 doi:10.1093/brain/117.6.1357 pmid:7820572

   CrossRefPubMedWeb of Science
6. 6.↵
   1. McKelvie P,
   2. Marotta R,
   3. Thorburn DR, et al

   . A case of myelopathy, myopathy, peripheral neuropathy and subcortical grey matter degeneration associated with recessive compound heterozygous POLG1 mutations. Neuromuscul Disord 2012;22:401–05 doi:10.1016/j.nmd.2011.10.017 pmid:22357363

   CrossRefPubMed
7. 7.↵
   1. von Elm E,
   2. Altman DG,
   3. Egger M

   , STROBE Initiative, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–57 doi:10.1016/S0140-6736(07)61602-X pmid:18064739

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Uluc K,
   2. Baskan O,
   3. Yildirim KA, et al

   . Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: a genetically proven case with distinct MRI findings. J Neurol Sci 2008;273:118–22 doi:10.1016/j.jns.2008.06.002 pmid:18619624

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Yamashita S,
   2. Miyake N,
   3. Matsumoto N, et al

   . Neuropathology of leukoencephalopathy with brainstem and spinal cord involvement and high lactate caused by a homozygous mutation of DARS2. Brain Dev 2013;35:312–16 doi:10.1016/j.braindev.2012.05.007 pmid:22677571

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Nikali K,
    2. Suomalainen A,
    3. Saharinen J, et al

    . Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 2005;14:2981–90 doi:10.1093/hmg/ddi328 pmid:16135556

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Bindu PS,
    2. Arvinda H,
    3. Taly AB, et al

    . Magnetic resonance imaging correlates of genetically characterized patients with mitochondrial disorders: a study from south India. Mitochondrion 2015;25:6–16 doi:10.1016/j.mito.2015.08.002 pmid:26341968

    CrossRefPubMed
12. 12.↵
    1. Mauri E,
    2. Dilena R,
    3. Boccazzi A, et al

    . Subclinical Leber’s hereditary optic neuropathy with pediatric acute spinal cord onset: more than meets the eye. BMC Neurol 2018;18:220 doi:10.1186/s12883-018-1227-9 pmid:30591017

    CrossRefPubMed
13. 13.
    1. Miyauchi A,
    2. Osaka H,
    3. Nagashima M, et al

    . Leigh syndrome with spinal cord involvement due to a hemizygous NDUFA1 mutation. Brain Dev 2018;40:498–502 doi:10.1016/j.braindev.2018.02.007 pmid:29506883

    CrossRefPubMed
14. 14.↵
    1. Tenney JR,
    2. Prada CE,
    3. Hopkin RJ, et al

    . Early spinal cord and brainstem involvement in infantile Leigh syndrome possibly caused by a novel variant. J Child Neurol 2013;28:1681–85 doi:10.1177/0883073812464273 pmid:23143729

    CrossRefPubMed
15. 15.↵
    1. Sparaco M,
    2. Cavallaro T,
    3. Rossi G, et al

    . Immunohistochemical demonstration of spinal ventral horn cells involvement in a case of “myoclonus epilepsy with ragged red fibers” (MERRF). Clin Neuropathol 2000;19:200–07 pmid:10919352

    PubMed
16. 16.↵
    1. Barz H,
    2. Henker J

    . Pathological findings in subacute necrotizing encephalomyelopathy (Leigh’s disease) (author’s transl). Zentralbl Allg Pathol 1975;119:488–94 pmid:1210838

    PubMed
17. 17.↵
    1. Leigh D

    . Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 1951;14:216–21 doi:10.1136/jnnp.14.3.216 pmid:14874135

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Wingerchuk DM,
    2. Banwell B,
    3. Bennett JL, et al

    . International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177–89 doi:10.1212/WNL.0000000000001729 pmid:26092914

    CrossRefPubMed
19. 19.↵
    1. Simão LM

    . Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report. Arq Bras Oftalmol 2012;75:280–82 doi:10.1590/s0004-27492012000400013 pmid:23258662

    CrossRefPubMed
20. 20.↵
    1. McClelland CM,
    2. Van Stavern GP,
    3. Tselis AC

    . Leber hereditary optic neuropathy mimicking neuromyelitis optica. J Neuroophthalmol 2011;31:265–68 doi:10.1097/WNO.0b013e318225247b pmid:21734595

    CrossRefPubMed
21. 21.↵
    1. Hudson G,
    2. Mowbray C,
    3. Elson JL, et al

    . Does mitochondrial DNA predispose to neuromyelitis optica (Devic’s disease)? Brain 2008;131:e93–93 doi:10.1093/brain/awm224 pmid:17967805

    CrossRefPubMed
22. 22.↵
    1. Zhang Q,
    2. Raoof M,
    3. Chen Y, et al

    . Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464:104–07 doi:10.1038/nature08780 pmid:20203610

    CrossRefPubMedWeb of Science
23. 23.↵
    1. West AP,
    2. Shadel GS

    . Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol 2017;17:363–75 doi:10.1038/nri.2017.21 pmid:28393922

    CrossRefPubMed
24. 24.↵
    1. Yamashita K,
    2. Kinoshita M,
    3. Miyamoto K, et al

    . Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder. Neuroinflammation 2018;15:125 doi:10.1186/s12974-018-1162-0 pmid:29703264

    CrossRefPubMed
25. 25.↵
    1. Di Filippo M,
    2. Chiasserini D,
    3. Tozzi A, et al

    . Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimers Dis 2010;20:S369–79 doi:10.3233/JAD-2010-100543 pmid:20463396

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Dubey D,
    2. Pittock SJ,
    3. Krecke KN, et al

    . Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol 2019;76:301–09 doi:10.1001/jamaneurol.2018.4053 pmid:30575890

    CrossRefPubMed
27. 27.↵
    1. De Angelis F,
    2. Brownlee WJ,
    3. Chard DT, et al

    . New MS diagnostic criteria in practice. Pract Neurol 2019;19:64–67 doi:10.1136/practneurol-2018-001945 pmid:30244196

    FREE Full Text
28. 28.↵
    1. Pfeffer G,
    2. Burke A,
    3. Yu-Wai-Man P, et al

    . Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology 2013;81:2073–81 doi:10.1212/01.wnl.0000437308.22603.43 pmid:24198293

    Abstract/FREE Full Text
29. 29.↵
    1. Bittner F,
    2. Falardeau J,
    3. Spain RI

    . Myelin oligodendrocyte glycoprotein antibody-associated demyelination comorbid with Leber hereditary optic neuropathy. JAMA Neurol 2019;76:227–28 doi:10.1001/jamaneurol.2018.3207 pmid:30422222

    CrossRefPubMed
30. 30.↵
    1. Cheng H,
    2. Zeng J,
    3. Li H, et al

    . Neuroimaging of HFMD infected by EV71. Radiol Infect Dis 2015;1:103–08 doi:10.1016/j.jrid.2015.02.006

    CrossRef
31. 31.↵
    1. Pathak D,
    2. Berthet A,
    3. Nakamura K

    . Energy failure: does it contribute to neurodegeneration? Ann Neurol 2013;74:506–16 doi:10.1002/ana.24014 pmid:24038413

    CrossRefPubMed
32. 32.↵
    1. Vargas MI,
    2. Gariani J,
    3. Sztajzel R, et al

    . Spinal cord ischemia: practical imaging tips, pearls, and pitfalls. AJNR Am J Neuroradiol 2015;36:825–30 doi:10.3174/ajnr.A4118 pmid:25324492

    Abstract/FREE Full Text